References
- Akbulut G. Tıbbi beslenme tedavisinde güncel uygulamalar IV; nörolojik hastalıklarda tıbbi beslenme tedavisi. Ankara: Ankara Nobel Tıp Kitabevi 2015.
- İnce T, Aydın A. Nutrition in patients with neurological problems. Turkiye Klinikleri J Pediatr Sci 2014;10(3):121–26.
- Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MGM, Bloem BR, Roos RA. Weight loss in neurodegenerative disorders. J Neurol 2008;255(12):1872–80. doi:10.1007/s00415-009-0062-8.
- Genton L, Viatte V, Janssens JP, Héritier AC, Pichard C. Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients. Clin Nutr 2011;30(5):553–59. doi:10.1016/j.clnu.2011.06.004.
- Akbulut G. Parkinson’s disease and dietary therapy. Dirim Tıp Gazetesi 2009;84(2):51–58.
- Cekici H, Sanlier N. Current nutritional approaches in managing autism spectrum disorder: A review. Nutr Neurosci 2017;5:1–11. doi:10.1080/1028415X.2017.1358481.
- Kasote DM, Hegde MV, Katyare SS. Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy. BioFactors 2013;39(4):392–406. doi:10.1002/biof.1093.
- Acar Tek N, Ağagündüz D, Çelik B, Bozbulut R. Estimation of resting energy expenditure: validation of previous and new predictive equations in obese children and adolescents. J Am Coll Nutr 2017;36(6):470–80. doi:10.1080/07315724.2017.1320952.
- Harris JA, Benedict FG. A biometric study of human basal metabolism. Proc Natl Acad Sci USA 1918;4(12):370–73.
- Schofield WN. Predicting basal metabolic, new standards and review of previous work. Hum Nutr Clin Nutr 1985;39(1):5–41.
- Siirala W, Olkkola KT, Noponen T, Vuori A, Aanta R. Predictive equations over-estimate the resting energy expenditure in amyotrophic lateral sclerosis patients who are dependent on invasive ventilation support. Nutr Metab 2010;7:70. doi:10.1186/1743-7075-7-70.
- Marra M, Cioffi I, Sammarco R, Montagnese C, Naccarato M, Amato V, et al. Prediction and evaluation of resting energy expenditure in a large group of obese outpatients. Int J Obes (Lond 2017;41(5):697–705. doi:10.1038/ijo.2017.34.
- Capecci M, Petrelli M, Emanuelli B, Millevolte M, Nicolai A, Provinciali L, et al. Rest energy expenditure in Parkinson’s disease: role of disease progression and dopaminergic therapy. Parkinsonism Relat Disord 2013;19(2):238–41. doi:10.1016/j.parkreldis.2012.10.016.
- Delikanaki-Skaribas E, Trail M, Wai-Lun Wong W, Lai EC. Daily energy expenditure, physical activity, and weight loss in Parkinson’s disease patients. Mov Disord 2009;24(5):667–71. doi:10.1002/mds.22372.
- Muscaritoli M, Kushta I, Molfino A, Inghilleri M, Sabatelli M, Rossi Fanelli F. Nutritional and metabolic support in patients with amyotrophic lateral sclerosis. Nutrition 2012;28(10):959–66. doi:10.1016/j.nut.2012.01.011.
- Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 2009;256(8):1236–42. doi:10.1007/s00415-009-5100-z.
- Lee J, Baek H, Kim SH, Park Y. Association between estimated total daily energy expenditure and stage of amyotrophic lateral sclerosis. Nutrition 2017;33:181–86. doi:10.1016/j.nut.2016.06.007.
- Kasarskis EJ, Mendiondo MS, Matthews DE, Mitsumoto H, Tandan R, Simmons Z, et al. Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis. Am J Clin Nutr 2014;99(4):792–803. doi:10.3945/ajcn.113.069997.
- Mähler A, Steiniger J, Endres M, Paul F, Boschmann M, Doss S. Increased catabolic state in spinocerebellar ataxia type 1 patients. Cerebellum 2014;13(4):440–46. doi:10.1007/s12311-014-0555-6.
- Gaba AM, Zhang K, Marder K, Moskowitz CB, Werner P, Boozer CN. Energy balance in early-stage Huntington’s disease. Am J Clin Nutr 2005;81(6):1335–41.
- Pratley RE, Salbe AD, Ravussin E, Caviness JN. Higher sedentary energy expenditure in patients with Huntington’s disease. Ann Neurol 2000;47(1):64–70.
- Gaba A, Kuan Zhang K, Moskowitz CB, Boozer CN. Harris–benedict equation estimations of energy needs as compared to measured 24-h energy expenditure by indirect calorimetry in people with early to mid-stage Huntington’s disease. Nutr Neurosci 2008;11(5):213–18. doi:10.1179/147683008X344129.
- Poehlman ET, Dvorak RV. Energy expenditure, energy intake, and weight loss in Alzheimer disease. Am J Clin Nutr 2000;71(2):650–5.
- Garcia-Contreras AA, Vásquez-Garibay EM, Romero-Velarde E, Ibarra-Gutiérrez AI. Energy expenditure in children with cerebral palsy and moderate/severe malnutrition during nutritional recovery. Nutr Hosp 2015;31(5):2062–69. doi:10.3305/nh.2015.31.5.8588.
- Bell KL, Davies PSW. Energy expenditure and physical activity of ambulatory children with cerebral palsy and of typically developing children1–3. Am J Clin Nutr 2010;92(2):313–19. doi:10.3945/ajcn.2010.29388.
- Rieken R, van Goudoever JB, Schierbeek H, Willemsen SP, Calis EA, Tibboel D, et al. Measuring body composition and energy expenditure in children with severe neurologic impairment and intellectual disability. Am J Clin Nutr 2011;94(3):759–66. doi:10.3945/ajcn.110.003798.
- Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985;39(1):5–41.
- Lin T, Liou C, Chen S, Chuang Y, Tiao M, Wang PW, et al. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson’s disease. Chang Gung Med J 2009;32(6):589–99.
- Chinta SJ, Andersen JK. Nitrosylation and nitration of mitochondrial complex I in Parkinson’s disease. Free Radic Res 2011;45(1):53–58. doi:10.3109/10715762.2010.509398.
- Marella M, Seo BB, Yagi T, Matsuno-Yagi A. Parkinson’s disease and mitochondrial complex I: a perspective on the Ndi1 therapy. J Bioenerg Biomembr 2009;41(6):493–7. doi:10.1007/s10863-009-9249-z.
- Jorgensen HU, Werdelin L, Annemette Lokkegaard A, Westerterp KR, Simonsen L. Free-living energy expenditure reduced after deep brain stimulation surgery for Parkinson’s disease. Clin Physiol Funct Imaging 2012;32(3):214–20. doi:10.1111/j.1475-097X.2011.01079.x.
- Lopes C, Rego AC. Revisiting mitochondrial function and metabolism in pluripotent stem cells: where do we stand in neurological diseases? Mol Neurobiol 2017;54(3):1858–73. doi:10.1007/s12035-016-9714-8.
- Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis 2005;2(3–4):202–07. doi:10.1159/000089626.
- Georges M, Morélot-Panzini C, Similowski T, Gonzalez- Bermejo J. Noninvasive ventilation reduces energy expenditure in amyotrophic lateral sclerosis. BMC Pulmo Med 2014;14:17. doi:10.1186/1471-2466-14-17.
- Sherman MS, Pillai A, Jackson A, Heiman-Patterson T. Standard equations are not accurate in assessing resting energy expenditure in patients with amyotrophic lateral sclerosis. J Parenter Enteral Nutr 2004;28(6):442–42. doi:10.1177/0148607104028006442.
- Shimizu T, Ishikawa-Takata K, Sakata A, Nagaoka U, Ichihara N, Ishida C, et al. The measurement and estimation of total energy expenditure in Japanese patients with ALS: a doubly labelled water method study. Amyotroph Lat Scl Fr 2017;18(1–2):37–45. doi:10.1080/21678421.2016.1245756.
- Ichihara N, Namba K, Ishikawa-Takata K, Sekine K, Takase M, Kamada Y, et al. Energy requirement assessed by doubly-labeled water method in patients with advanced amyotrophic lateral sclerosis managed by tracheotomy positive pressure ventilation. Amyotroph Lateral Scler 2012;13(6):544–49. doi:10.3109/17482968.2012.699968.
- Oyanagi K, Mochizuki Y, Nakayama Y, Hayashi K, Shimizu T, Nagao M, et al. Marked preservation of the visual and olfactory pathways in ALS patients in a totally locked-in state. Clin Neuropathol 2015;34(5):267–74. doi:10.5414/NP300859.
- Foley N, Marshall S, Pikul J, Salter K, Teasell R. Hypermetabolism following moderate to severe traumatic acute brain injury: a systematic review. J Neurotrauma 2008;25(12):1415–31. doi:10.1089/neu.2008.0628.
- Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol 2001;248(7):612–16.
- Ellis AC, Rosenfeld J. Which equation best predicts energy expenditure in amyotrophic lateral sclerosis? J Am Diet Assoc 2011;111(11):1680–87. doi:10.1016/j.jada.2011.08.002.
- Park Y, Park J, Kim Y, Baek H, Kim SH. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients. Nutrition 2015;31(11–12):1362–67. doi:10.1016/j.nut.2015.05.025.
- Rüb U, Bürk K, Timmann D, Dunnen den W, Seidel K, Farrag K, et al. Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights. Neuropathol Appl Neurobiol 2012;38(7):665–80. doi:10.1111/j.1365-2990.2012.01259.x.
- Şahin HA. Huntington disease. Turkiye Klinikleri J Neurol-Special Topics 2016;9(1):30–34.
- Aziz NA, Pijl H, Frolich M, Snel M, Streefland TC, Roelfsema F, et al. Systemic energy homeostasis in Huntington’s disease patients. J Neurol Neurosurg Psychiatry 2010;81(11):1233–37. doi:10.1136/jnnp.2009.191833.
- Chiang MC, Chern Y, Huang RN. PPARgamma rescue of the mitochondrial dysfunction in Huntington’s disease. Neurobiol Dis 2012;45(1):322–28. doi:10.1016/j.nbd.2011.08.016.
- Chen H, Chan DC. Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases. Hum Mol Genet 2009;18(R2):R169–76. doi:10.1093/hmg/ddp326.
- Goedert M, Spillantini MG. A century of Alzheimer’s disease. Science 2006;314(5800):777–81. doi:10.1126/science.1132814.
- Swegert CV, Dave KR, Katyare SS. Effect of aluminiuminduced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria. Mech Age Dev 1999;112(1):27–42. doi:10.1016/S0047-6374(99)00051-2.
- Hoekstra JG, Montine KS, Zhang J, Montine TJ. Mitochondrial therapeutics in Alzheimer’s disease and Parkinson’s disease. Alzheimers Res Ther 2011;3:21. doi:10.1186/alzrt83.
- Mancuso M, Orsucci D, LoGerfo A, Calsolaro V, Siciliano G. Clinical features and pathogenesis of Alzheimer’s disease: involvement of mitochondria and mitochondrial DNA. Adv Exp Med Biol 2010;685:34–44.
- Cai H, Cong W, Ji S, Rothman S, Maudsley S, Martin B. Metabolic dysfunction in Alzheimer’s disease and related neurodegenerative disorders. Curr Alzheimer Res 2012;9(1):5–17.
- Jéquier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002;967:379–88. doi:10.1111/j.1749-6632.2002.tb04293.x.
- Power DA, Noel J, Collins R, O’Neill D. Circulating leptin levels and weight loss in Alzheimer’s disease patients. Dement Geriatr Cogn Disord 2001;12(2):167–70. doi:10.1159/000051252.
- Niskanen L, Piirainen M, Koljonen M, Uusitupa M. Resting energy expenditure in relation to energy intake in patients with Alzheimer’s disease, multi-infarct dementia and in control women. Age Ageing 1993;22(2):132–37.
- Murphy J, Holmes J, Brooks C. Measurements of daily energy intake and total energy expenditure in people with dementia in care homes: The use of wearable technology. J Nutr Health Aging 2017;21(8):927–32. doi:10.1007/s12603-017-0870-y.
- Sergi G, De Rui M, Coin A, Meral Inelman E, Manzato E. Weight loss and Alzheimer’s disease: temporal and aetiologic connections. Proc Nutr Soc 2013;72(1):160–65. doi:10.1017/S0029665112002753.
- Mähler A, Steiniger J, Bock M, Klug L, Parreidt N, Lorenz M, Zimmermann BF, et al. Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial1–5. Am J Clin Nutr 2015;101(3):487–95. doi:10.3945/ajcn.113.075309.
- Deisenhammer F, Balogh D, Grubwieser G, Pohl P. Hypermetabolism in multiple sclerosis patients. Eur J Neurol 1997;4(4):342–47. doi:10.1111/j.1468-1331.1997.tb00359.x.
- Mähler A, Steiniger J, Bock M, Brandt AU, Haas V, Boschmann M, et al. Is metabolic flexibility altered in multiple sclerosis patients? PLoS ONE 2012;7(8):e43675. doi:10.1371/journal.pone.0043675.
- Coote S, O’Dwyer C. Energy expenditure during everyday activities a study comparing people with varying mobility limitations due to multiple sclerosis and healthy controls. Disabil Rehabil 2014;36(24):2059–64. doi:10.3109/09638288.2014.890676.
- Marvi-Esfahani M, Karimi MT, Etemadifar M, Fatoye F. Comparison of energy consumption in different clinical forms multiple sclerosis with normal subjects (cohort study). Mult Scler Relat Disord 2016;6:97–101. doi:10.1016/j.msard.2016.02.007.
- Sandroff BM, Motl RW, Suh Y. Accelerometer output and its association with energy expenditure in persons with multiple sclerosis. J Rehabil Res Dev 2012;49(3):467–75. doi:10.1682/JRRD.2011.03.0063.
- El-Shamy SM, Abdelaal AAM. Walkaide efficacy on gait and energy expenditure in children with hemiplegic cerebral palsy: a randomized controlled trial. Am J Phys Med Rehabil 2016;95(9):629–38. doi:10.1097/PHM.0000000000000514.
- Stallings VA, Zemel BS, Davies JC, Cronk CE, Charney EB. Energy expenditure of children and adolescents with severe disabilities: a cerebral palsy model. Am J Clin Nutr 1996;64(4):627–34.
- Fiona E, Arrowsmith FE, Allen JC, Gaskin KJ, Somerville H, Birdsall J. Nutritional rehabilitation increases the resting energy expenditure of malnourished children with severe cerebral palsy. Dev Med Child Neurol 2012;54(2):170–75. doi:10.1111/j.1469-8749.2011.04166.x.
- Ünsal N, Acar Tek N. Determination of nutritional problems and energy requirements in children with cerebral palsy. Mersin Univ Saglık Bilim Derg 2017;10(2):132–41. doi:10.26559/mersinsbd.300992.
- Caliskan Uckun A, Çelik C, Ucan H, Ordu Gokkaya NK. Comparison of effects of lower extremity orthoses on energy expenditure in patients with cerebral palsy. Dev Neurorehabil 2014;17(6):388–92. doi:10.3109/17518423.2013.830653.
- Gurka MJ, Kuperminc MN, Busby MG, Bennis JA, Grossberg RI, Houlihan CM, et al. Assessment and correction of skinfold thickness equations in estimating body fat in children with cerebral palsy. Dev Med Child Neurol 2010;52(2):e35–41. doi:10.1111/j.1469-8749.2009.03474.x.
- Krick J, Murphy PE, Markham JF, Shapiro BK. A proposed formula for calculating energy needs of children with cerebral palsy. Dev Med Child Neurol 1992;34(6):481–7. doi:10.1111/j.1469-8749.1992.tb11468.x.
- Pencharz PB, Azcue M. Use of bioelectrical impedance analysis measurements in the clinical management of malnutrition. Am J Clin Nutr 1996;64(3):485–8.
- Ryan JM, Walsh M, Gormley J. A comparison of three accelerometry-based devices for estimating energy expenditure in adults and children with cerebral palsy. J Neuroeng Rehabil 2014;11:116. doi:10.1186/1743-0003-11-116.
- Norman JF, Bossman S, Gardner P, Moen C. Comparison of the energy expenditure index and oxygen consumption index during self-paced walking in children with spastic diplegia cerebral palsy and children without physical disabilities. Pediatr Phys Ther 2004;16(4):206–11. doi:10.1097/01.PEP.0000145930.84009.23.
- Rose J, Gamble JG, Burgos A, Medeiros J, Haskell WL. Energy expenditure index of walking for normal children and for children with cerebral palsy. Dev Med Child Neurol 1990;32(4):333–40.
- Bratteby Tollerz LU, Forslund AH, Olsson RM, Lidström H, Holmbäck U. Children with cerebral palsy do not achieve healthy physical activity levels. Acta Pædiatr 2015;104(11):1125–29. doi:10.1111/apa.13141.